Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD
Rattachement africain : fr. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Introduction Furosemide is commonly prescribed to patients with CKD but may impair the kidney's excretion of protein-bound uraemic toxins (PBUTs) via the organic anion transporters 1 and 3 (OAT1/OAT3). We evaluated the association between the furosemide prescription (status and dose level) and the serum concentrations of free OAT1/3-inhibiting uraemic toxins (UTs) in patients with CKD. Methods We included 2,342 patients with CKD (stages 2–5) from the CKD-REIN cohort and with centralized serum UT assay data at baseline. The UTs were assayed using liquid chromatography - tandem mass spectrometry. The OAT1/3-inhibiting UTs identified in a literature review included indoxyl sulphate (IS), kynurenine (Kyn), p-cresyl sulphate (PCS), and indole-3-acetic acid (IAA). Multiple linear regression was used to assess each PBUT or their sum ( Σ UTs free ) as the dependent variable. Results Patients prescribed furosemide (n=799, 34%) were older and had a lower estimated glomerular filtration rate, a higher C-reactive protein concentration, more comorbidities and more concomitant medications than patients not prescribed furosemide. After adjustment for potential confounders, patients prescribed >120 mg furosemide had significantly higher serum concentrations of Σ UTs free (+19.1%), IS (+31.9%), Kyn (+9.3%), PCS (+29.3%) and IAA (+16.9%) than patients not prescribed furosemide. Using a smooth function to model the association between the furosemide dose level and PBUTs, we observed (for Σ UTs free and each free UT) a steep increase between 80 and 100 mg and then a high plateau. Conclusion In patients with CKD, furosemide (particularly at a dose level >100 mg) is independently associated with higher serum free PBUT concentrations. Our findings suggested that drug-UT competition contributes to PBUT accumulation.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD
- Date Crossref
- 01/07/2025
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.